Mitochondrially targeted antioxidants for the treatment of cardiovascular diseases

Recent Patents on Cardiovascular Drug Discovery

Volumn 5, Issue 1, 2010, Pages 54-65

  Subramanian, Sharath ^a   Kalyanaraman, Balaraman ^a   Migrino, Raymond Q ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Antioxidant therapy; Antioxidants; Apoptosis; Atherosclerosis; Cardiomyopathy; Mitochondria; Oxidative stress; Reactive oxygen species (ROS); Vitamin E

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; DOXORUBICIN; FLUOROURACIL; FREE RADICAL; GLUTATHIONE; GLUTATHIONE CHOLINE ESTER; MANGANESE SUPEROXIDE DISMUTASE; MITOCHONDRIAL DNA; MITOPHENYLTERTBUTYLNITRONE; MITOQUINONE; MITOVITAMIN E; N TERT BUTYL ALPHA PHENYLNITRONE; PLASTOQUINONE; REACTIVE OXYGEN METABOLITE; SS 02; SS 31; UBIQUINOL CYTOCHROME C REDUCTASE; UBIQUINONE; UBIQUINONE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; APOPTOSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL PROTECTION; COMPARATIVE STUDY; DNA DAMAGE; DRUG TARGETING; EXPERIMENTAL MODEL; HEART FUNCTION; HUMAN; NONHUMAN; OXIDATIVE STRESS; PATENT; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; CARDIOVASCULAR DISEASES; CLINICAL TRIALS AS TOPIC; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; HUMANS; MITOCHONDRIA; OXIDATIVE STRESS; PATENTS AS TOPIC; REACTIVE OXYGEN SPECIES;

EID: 77951143920     PISSN: 15748901     EISSN: None     Source Type: Journal    
DOI: 10.2174/157489010790192601     Document Type: Review

References (133)

1. Health, United States, 2008 With Chartbook. National Center for Health Statistics. Hyattsville MD 2009.
2. Harrison D, Griendling KK, Landmesser U, Hornig B, Drexler H. Role of oxidative stress in atherosclerosis. Am J Cardiol 2003; 91(3A): 7A-11A.
3. Parthasarathy S, Steinberg D, Witztum JL. The role of oxidized low-density lipoproteins in the pathogenesis of atherosclerosis. Annu Rev Med 1992; 43: 219-225.
4. Betteridge DJ. What is oxidative stress? Metabolism 2000; 49(2-1): 3-8.
5. Pandya DP. Oxidant injury in coronary heart disease (Part-I). Compr Ther 2001; 27(4): 284-292. (Pubitemid 33108193)
6. Witztum JL. The oxidation hypothesis of atherosclerosis. Lancet 1994; 344(8925): 793-795.
7. Gutteridge JM, Mitchell J. Redox imbalance in the critically ill. Br Med Bull 1999; 55(1): 49-75.
8. Rocha M, Victor VM. Targeting antioxidants to mitochondria and cardiovascular diseases: The effects of mitoquinone. Med Sci Monit 2007; 13(7): RA132-145.
9. Droge W. Free radicals in the physiological control of cell function. Physiol Rev 2002; 82(1): 47-95. (Pubitemid 34654215)
10. Gutteridge JM. Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem 1995; 41(12 Pt 2): 1819-1828.
11. Leeuwenburgh C, Hardy MM, Hazen SL, et al. Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima. J Biol Chem 1997; 272(3): 1433-1436.
12. Kritharides L, Stocker R. The use of antioxidant supplements in coronary heart disease. Atherosclerosis 2002; 164(2): 211-219. (Pubitemid 35223069)
13. Meagher EA. Treatment of atherosclerosis in the new millennium: Is there a role for vitamin E? Prevent Cardiol 2003; 6(2): 85-90.
14. Beckman KB, Ames BN. The free radical theory of aging matures. Physiol Rev 1998; 78(2): 547-581. (Pubitemid 28182903)
15. Kowaltowski AJ, Vercesi AE. Mitochondrial damage induced by conditions of oxidative stress. Free Rad Biol Med 1999; 26(3-4): 463-471. (Pubitemid 29013479)
16. Szeto HH. Mitochondria-targeted peptide antioxidants: Novel neuroprotective agents. AAPS J 2006; 8(3): E521-531.
17. Asmis R, Begley JG. Oxidized LDL promotes peroxide-mediated mitochondrial dysfunction and cell death in human macrophages: A caspase-3-independent pathway. Circ Res 2003; 92(1): e20-29.
18. Ballinger SW, Patterson C, Knight-Lozano CA, et al. Mitochondrial integrity and function in atherogenesis. Circulation 2002; 106(5): 544-549.
19. Gvozdjakova A, Bada V, Sany L, et al. Smoke cardiomyopathy: Disturbance of oxidative processes in myocardial mitochondria. Cardiovasc Res 1984; 18(4): 229-232. (Pubitemid 14131661)
20. Knight-Lozano CA, Young CG, Burow DL, et al. Cigarette smoke exposure and hypercholesterolemia increase mitochondrial damage in cardiovascular tissues. Circulation 2002; 105(7): 849-854.
21. Li M, Absher PM, Liang P, Russell JC, Sobel BE, Fukagawa NK. High glucose concentrations induce oxidative damage to mitochondrial DNA in explanted vascular smooth muscle cells. Exp Biol Med (Maywood) 2001; 226(5): 450-457.
22. van Jaarsveld H, Kuyl JM, Alberts DW. Exposure of rats to low concentration of cigarette smoke increases myocardial sensitivity to ischaemia/reperfusion. Basic Res Cardiol 1992; 87(4): 393-399.
23. Yao PM, Tabas I. Free cholesterol loading of macrophages is associated with widespread mitochondrial dysfunction and activation of the mitochondrial apoptosis pathway. J Biol Chem 2001; 276(45): 42468-42476. (Pubitemid 37371159)
24. Matthews RT, Yang L, Browne S, Baik M, Beal MF. Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects. Proc Natl Acad Sci USA 1998; 95(15): 8892-8897.
25. Victor VM, Rocha M, De la Fuente M. N-acetylcysteine protects mice from lethal endotoxemia by regulating the redox state of immune cells. Free Radic Res 2003; 37(9): 919-929. (Pubitemid 37221024)
26. Victor VM, Rocha M, De la Fuente M. Immune cells: Free radicals and antioxidants in sepsis. Int Immunopharmacol 2004; 4(3): 327-347. (Pubitemid 38375967)
27. Victor VM, Rocha M, Esplugues JV, De la Fuente M. Role of free radicals in sepsis: Antioxidant therapy. Curr Pharm Des 2005; 11(24): 3141-3158. (Pubitemid 41149930)
28. Kagan VE, Serbinova EA, Stoyanovsky DA, Khwaja S, Packer L. Assay of ubiquinones and ubiquinols as antioxidants. Method Enzymol 1994; 234: 343-354.
29. Murphy MP, Smith RA. Targeting antioxidants to mitochondria by conjugation to lipophilic cations. Annu Rev Pharmacol Toxicol 2007; 47: 629-656. (Pubitemid 46272141)
30. Sheu SS, Nauduri D, Anders MW. Targeting antioxidants to mitochondria: A new therapeutic direction. Biochim Biophys Acta 2006; 1762(2): 256-265. (Pubitemid 43006031)
31. Victor VM, McCreath KJ, Rocha M. Recent progress in pharmacological research of antioxidants in pathological conditions: cardiovascular health. Recent Pat Antiinfect Drug Discov 2006; 1(1): 17-31.
32. Gutierrez J, Ballinger SW, Darley-Usmar VM, Landar A. Free radicals, mitochondria, and oxidized lipids: The emerging role in signal transduction in vascular cells. Circ Res 2006; 99(9): 924-932. (Pubitemid 44657795)
33. Patel RP, Moellering D, Murphy-Ullrich J, Jo H, Beckman JS, Darley-Usmar VM. Cell signaling by reactive nitrogen and oxygen species in atherosclerosis. Free Rad Biol Med 2000; 28(12): 1780-1794.
34. Turrens JF. Mitochondrial formation of reactive oxygen species. J Physiol 2003; 552(2): 335-344. (Pubitemid 37321833)
35. Halliwell B. Antioxidants: The basics - what they are and how to evaluate them. Adv Pharmacol 1997; 38: 3-20.
36. Halliwell B. Oxidative stress, nutrition and health. Experimental strategies for optimization of nutritional antioxidant intake in humans. Free Radic Res 1996; 25(1): 57-74.
37. McDermott JH. Antioxidant nutrients: Current dietary recommendations and research update. J Am Pharm Assoc (Wash) 2000; 40(6): 785-799.
38. Victor VM, Rocha M. Targeting antioxidants to mitochondria: A potential new therapeutic strategy for cardiovascular diseases. Curr Pharm Des 2007; 13(8): 845-863.
39. Bulteau AL, Szweda LI, Friguet B. Mitochondrial protein oxidation and degradation in response to oxidative stress and aging. Exp Gerontol 2006; 41(7): 653-657.
40. Wei YH. Oxidative stress and mitochondrial DNA mutations in human aging. Proc Soc Exp Biol Med 1998; 217(1): 53-63. (Pubitemid 28023570)
41. Gilkerson RW. Mitochondrial DNA nucleoids determine mitochondrial genetics and dysfunction. Int J Biochem Cell Biol 2009; 41(10): 1899-1906.
42. Larsen NB, Rasmussen M, Rasmussen LJ. Nuclear and mitochondrial DNA repair: Similar pathways? Mitochondrion 2005; 5(2): 89-108.
43. Ballinger SW. Mitochondrial dysfunction in cardiovascular disease. Free Rad Biol Med 2005; 38(10): 1278-1295.
44. Corral-Debrinski M, Shoffner JM, Lott MT, Wallace DC. Association of mitochondrial DNA damage with aging and coronary atherosclerotic heart disease. Mutat Res 1992; 275(3-6): 169-180.
45. Adlam VJ, Harrison JC, Porteous CM, et al. Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury. FASEB J 2005; 19(9): 1088-1095.
46. Murphy MP. Selective targeting of bioactive compounds to mitochondria. Trends Biotechnol 1997; 15(8): 326-330.
47. Murphy MP, Smith RA. Drug delivery to mitochondria: The key to mitochondrial medicine. Adv Drug Deliv Rev 2000; 41(2): 235-250.
48. Schriner SE, Linford NJ, Martin GM, et al. Extension of murine life span by overexpression of catalase targeted to mitochondria. Science 2005; 308(5730): 1909-1911.
49. Berliner JA, Heinecke JW. The role of oxidized lipoproteins in atherogenesis. Free Rad Biol Med 1996; 20(5): 707-727.
50. Heinecke JW. Oxidants and antioxidants in the pathogenesis of atherosclerosis: Implications for the oxidized low density lipoprotein hypothesis. Atherosclerosis 1998; 141(1): 1-15.
51. Steinberg D. A critical look at the evidence for the oxidation of LDL in atherogenesis. Atherosclerosis 1997; 131: S5-7.
52. Corral-Debrinski M, Stepien G, Shoffner JM, Lott MT, Kanter K, Wallace DC. Hypoxemia is associated with mitochondrial DNA damage and gene induction. Implications for cardiac disease. JAMA 1991; 266(13): 1812-1816.
53. Aliev G, Seyidova D, Neal ML, et al. Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels as a central target for the development of human AD and AD-like pathology in aged transgenic mice. Ann NY Acad Sci 2002; 977: 45-64.
54. Brookes PS, Zhang J, Dai L, et al. Increased sensitivity of mitochondrial respiration to inhibition by nitric oxide in cardiac hypertrophy. J Mol Cell Cardiol 2001; 33(1): 69-82.
55. Ide T, Tsutsui H, Hayashidani S, et al. Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction. Circ Res 2001; 88(5): 529-535.
56. Bonnefont-Rousselot D, Bastard JP, Jaudon MC, Delattre J. Consequences of the diabetic status on the oxidant/antioxidant balance. Diabetes Metab 2000; 26(3): 163-176. (Pubitemid 30435761)
57. Holland JA, Ziegler LM, Meyer JW. Atherogenic levels of low-density lipoprotein increase hydrogen peroxide generation in cultured human endothelial cells: Possible mechanism of heightened endocytosis. J Cell Physiol 1996; 166(1): 144-151.
58. Ito H, Torii M, Suzuki T. Decreased superoxide dismutase activity and increased superoxide anion production in cardiac hypertrophy of spontaneously hypertensive rats. Clin Exp Hypertens 1995; 17(5): 803-816.
59. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 1993; 91(6): 2546-2551. (Pubitemid 23182507)
60. Pratico D, Barry OP, Lawson JA, et al. IPF2alpha-I: An index of lipid peroxidation in humans. Proc Natl Acad Sci USA 1998; 95(7): 3449-3454.
61. Pratico D, Tangirala RK, Rader DJ, Rokach J, FitzGerald GA. Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice. Nat Med 1998; 4(10): 1189-1192.
62. Reilly M, Delanty N, Lawson JA, FitzGerald GA. Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation 1996; 94(1): 19-25.
63. Reilly MP, Pratico D, Delanty N, et al. Increased formation of distinct F2 isoprostanes in hypercholesterolemia. Circulation 1998; 98(25): 2822-2828.
64. Watts GF, Playford DA. Dyslipoproteinaemia and hyperoxidative stress in the pathogenesis of endothelial dysfunction in non-insulin dependent diabetes mellitus: An hypothesis. Atherosclerosis 1998; 141(1): 17-30.
65. Hink U, Li H, Mollnau H, et al. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res 2001; 88(2): E14-22.
66. Fahn HJ, Wang LS, Kao SH, Chang SC, Huang MH, Wei YH. Smoking-associated mitochondrial DNA mutations and lipid peroxidation in human lung tissues. Am J Respir Cell Mol Biol 1998; 19(6): 901-909.
67. Alonso JR, Cardellach F, Lopez S, Casademont J, Miro O. Carbon monoxide specifically inhibits cytochrome c oxidase of human mitochondrial respiratory chain. Pharmacol Toxicol 2003; 93(3): 142-146.
68. Lee HC, Lim ML, Lu CY, et al. Concurrent increase of oxidative DNA damage and lipid peroxidation together with mitochondrial DNA mutation in human lung tissues during aging - smoking enhances oxidative stress on the aged tissues. Arch Biochem Biophys 1999; 362(2): 309-316.
69. Miro O, Alonso JR, Jarreta D, Casademont J, Urbano-Marquez A, Cardellach F. Smoking disturbs mitochondrial respiratory chain function and enhances lipid peroxidation on human circulating lymphocytes. Carcinogenesis 1999; 20(7): 1331-1336.
70. Yang Z, Knight CA, Mamerow MM, et al. Prenatal environmental tobacco smoke exposure promotes adult atherogenesis and mitochondrial damage in apolipoprotein E-/- mice fed a chow diet. Circulation 2004; 110(24): 3715-3720.
71. Sastry BV, Chance MB, Hemontolor ME, Goddijn-Wessel TA. Formation and retention of cotinine during placental transfer of nicotine in human placental cotyledon. Pharmacology 1998; 57(2): 104-116. (Pubitemid 28345051)
72. Smith RA, Porteous CM, Coulter CV, Murphy MP. Selective targeting of an antioxidant to mitochondria. Eur J Biochem 1999; 263(3): 709-716.
73. Martinet W, Knaapen MW, De Meyer GR, Herman AG, Kockx MM. Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques. Circulation 2002; 106(8): 927-932.
74. Chen Z, Siu B, Ho YS, et al. Overexpression of MnSOD protects against myocardial ischemia/reperfusion injury in transgenic mice. J Mol Cell Cardiol 1998; 30(11): 2281-2289.
75. Asimakis GK, Lick S, Patterson C. Postischemic recovery of contractile function is impaired in SOD2(+/-) but not SOD1(+/-) mouse hearts. Circulation 2002; 105(8): 981-986. (Pubitemid 34184578)
76. Blanc J, Alves-Guerra MC, Esposito B, et al. Protective role of uncoupling protein 2 in atherosclerosis. Circulation 2003; 107(3): 388-390.
77. Teshima Y, Akao M, Jones SP, Marban E. Uncoupling protein-2 overexpression inhibits mitochondrial death pathway in cardiomyocytes. Circ Res 2003; 93(3): 192-200. (Pubitemid 36993229)
78. Armstrong JS. Mitochondrial medicine: Pharmacological targeting of mitochondria in disease. Br J Pharmacol 2007; 151(8): 1154-1165. (Pubitemid 47255892)
79. Torchilin VP. Drug targeting. Eur J Pharm Sci 2000; 11 (Suppl 2): S81-91.
80. Cipolat S, Rudka T, Hartmann D, et al. Mitochondrial rhomboid PARL regulates cytochrome c release during apoptosis via OPA1-dependent cristae remodeling. Cell 2006; 126(1): 163-175.
81. Frey TG, Mannella CA. The internal structure of mitochondria. Trends Biochem Sci 2000; 25(7): 319-324.
82. Frezza C, Cipolat S, Martins de Brito O, et al. OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell 2006; 126(1): 177-189.
83. Muratovska A, Lightowlers RN, Taylor RW, Wilce JA, Murphy MP. Targeting large molecules to mitochondria. Adv Drug Deliv Rev 2001; 49(1-2): 189-198.
84. Weissig V. Mitochondrial-targeted drug and DNA delivery. Crit Rev Ther Drug Carrier Syst 2003; 20(1): 1-62.
85. Weissig V. Targeted drug delivery to mammalian mitochondria in living cells. Expert Opin Drug Deliv 2005; 2(1): 89-102. (Pubitemid 40123885)
86. Reddy PH. Mitochondrial oxidative damage in aging and Alzheimer's disease: Implications for mitochondrially targeted antioxidant therapeutics. J Biomed Biotechnol 2006; 2006(3): 31372.
87. Demura M, Kamo N, Kobatake Y. Mitochondrial membrane potential estimated with the correction of probe binding. Biochim Biophys Acta 1987; 894(3): 355-364.
88. Asin-Cayuela J, Manas AR, James AM, Smith RA, Murphy MP. Fine-tuning the hydrophobicity of a mitochondria-targeted antioxidant. FEBS Lett 2004; 571(1-3): 9-16.
89. Calabrese V, Lodi R, Tonon C, et al. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia. J Neurol Sci 2005; 233(1-2): 145-162.
90. James AM, Cocheme HM, Murphy MP. Mitochondria-targeted redox probes as tools in the study of oxidative damage and ageing. Mech Ageing Dev 2005; 126(9): 982-986.
91. Abid MR, Schoots IG, Spokes KC, Wu SQ, Mawhinney C, Aird WC. Vascular endothelial growth factor-mediated induction of manganese superoxide dismutase occurs through redox-dependent regulation of forkhead and IkappaB/NF-kappaB. J Biol Chem 2004; 279(42): 44030-44038.
92. Filipovska A, Kelso GF, Brown SE, Beer SM, Smith RA, Murphy MP. Synthesis and characterization of a triphenylphosphonium-conjugated peroxidase mimetic. Insights into the interaction of ebselen with mitochondria. J Biol Chem 2005; 280(25): 24113-24126.
93. Smith, R.A.J., Murphy, M.P.: US7179928 (2007).
94. Taylor, K.M., Smith, R.: EP1664069 (2006).
95. Murphy, M.P., Smith, R.: WO2005019233 (2005).
96. Murphy, M.P., Smith, R.A.J.: WO2004014927 (2004).
97. Murphy, M.P., Smith, R.A.J.: WO99026954 (1999).
98. Skulachev, V.P.: WO2007046729 (2007).
99. Anders, M.W., Robotham, J.L., Sheu, S.S.: WO2007062343 (2007).
100. Grinius LL, Jasaitis AA, Kadziauskas YP, et al. Conversion of biomembrane-produced energy into electric form. I. Submitochondrial particles. Biochim Biophys Acta 1970; 216(1): 1-12.
101. Smith RA, Porteous CM, Gane AM, Murphy MP. Delivery of bioactive molecules to mitochondria in vivo. Proc Natl Acad Sci USA 2003; 100(9): 5407-5412.
102. Ernster L, Forsmark P, Nordenbrand K. The mode of action of lipid-soluble antioxidants in biological membranes: Relationship between the effects of ubiquinol and vitamin E as inhibitors of lipid peroxidation in submitochondrial particles. BioFactors (Oxford, England) 1992; 3(4): 241-248.
103. Maguire JJ, Wilson DS, Packer L. Mitochondrial electron transport-linked tocopheroxyl radical reduction. J Biol Chem 1989; 264(36): 21462-21465. (Pubitemid 20028701)
104. Kelso GF, Porteous CM, Coulter CV, et al. Selective targeting of a redox-active ubiquinone to mitochondria within cells: Antioxidant and antiapoptotic properties. J Biol Chem 2001; 276(7): 4588-4596.
105. Sies H. Strategies of antioxidant defense. Eur J Biochem 1993; 215(2): 213-219.
106. Dhanasekaran A, Kotamraju S, Kalivendi SV, et al. Supplementation of endothelial cells with mitochondria-targeted antioxidants inhibit peroxide-induced mitochondrial iron uptake, oxidative damage, and apoptosis. J Biol Chem 2004; 279(36): 37575-37587.
107. Jauslin ML, Meier T, Smith RA, Murphy MP. Mitochondria-targeted antioxidants protect Friedreich Ataxia fibroblasts from endogenous oxidative stress more effectively than untargeted antioxidants. FASEB J 2003; 17(13): 1972-1974.
108. Kalivendi SV, Konorev EA, Cunningham S, et al. Doxorubicin activates nuclear factor of activated T-lymphocytes and Fas ligand transcription: Role of mitochondrial reactive oxygen species and calcium. Biochem J 2005; 389(2): 527-539.
109. Schafer M, Schafer C, Ewald N, Piper HM, Noll T. Role of redox signaling in the autonomous proliferative response of endothelial cells to hypoxia. Circ Res 2003; 92(9): 1010-1015.
110. Apostolova N, Cervera AM, Victor VM, et al. Loss of apoptosis-inducing factor leads to an increase in reactive oxygen species, and an impairment of respiration that can be reversed by antioxidants. Cell Death Differ 2006; 13(2): 354-357.
111. Sanjuan-Pla A, Cervera AM, Apostolova N, et al. A targeted antioxidant reveals the importance of mitochondrial reactive oxygen species in the hypoxic signaling of HIF-1alpha. FEBS Lett 2005; 579(12): 2669-2674.
112. Plecita-Hlavata L, Jezek J, Jezek P. Pro-oxidant mitochondrial matrix-targeted ubiquinone MitoQ10 acts as anti-oxidant at retarded electron transport or proton pumping within Complex I. Int J Biochem Cell Biol 2009; 41(8-9): 1697-1707.
113. Christophe M, Nicolas S. Mitochondria: A target for neuroprotective interventions in cerebral ischemia-reperfusion. Curr Pharm Des 2006; 12(6): 739-757.
114. Ng Y, Barhoumi R, Tjalkens RB, et al. The role of docosahexaenoic acid in mediating mitochondrial membrane lipid oxidation and apoptosis in colonocytes. Carcinogenesis 2005; 26(11): 1914-1921.
115. Pletjushkina OY, Lyamzaev KG, Popova EN, et al. Effect of oxidative stress on dynamics of mitochondrial reticulum. Biochim Biophys Acta 2006; 1757(5-6): 518-524. (Pubitemid 43996946)
116. Kalyanaraman B, Joseph J, Kalivendi S, Wang S, Konorev E, Kotamraju S. Doxorubicin-induced apoptosis: implications in cardiotoxicity. Mol Cell Biochem 2002; 234-235(1-2): 119-124.
117. Kotamraju S, Konorev EA, Joseph J, Kalyanaraman B. Doxorubicin-induced apoptosis in endothelial cells and cardiomyocytes is ameliorated by nitrone spin traps and ebselen. Role of reactive oxygen and nitrogen species. J Biol Chem 2000; 275(43): 33585-33592.
118. Sawyer DB, Fukazawa R, Arstall MA, Kelly RA. Daunorubicin-induced apoptosis in rat cardiac myocytes is inhibited by dexrazoxane. Circ Res 1999; 84(3): 257-265. (Pubitemid 29095566)
119. Chandran K, Aggarwal D, Migrino RQ, et al. Doxorubicin inactivates myocardial cytochrome c oxidase in rats: Cardioprotection by Mito-Q. Biophys J 2009; 96(4): 1388-1398.
120. Doughan AK, Dikalov SI. Mitochondrial redox cycling of mitoquinone leads to superoxide production and cellular apoptosis. Antioxidant Redox Signal 2007; 9(11): 1825-1836.
121. Fink BD, O'Malley Y, Dake BL, Ross NC, Prisinzano TE, Sivitz WI. Mitochondrial targeted coenzyme Q, superoxide, and fuel selectivity in endothelial cells. PLoS One 2009; 4(1): e4250.
122. Mukherjee TK, Mishra AK, Mukhopadhyay S, Hoidal JR. High concentration of antioxidants N-acetylcysteine and mitoquinone-Q induces intercellular adhesion molecule 1 and oxidative stress by increasing intracellular glutathione. J Immunol 2007; 178(3): 1835-1844. (Pubitemid 46154656)
123. James AM, Cocheme HM, Smith RA, Murphy MP. Interactions of mitochondria-targeted and untargeted ubiquinones with the mitochondrial respiratory chain and reactive oxygen species. Implications for the use of exogenous ubiquinones as therapies and experimental tools. J Biol Chem 2005; 280(22): 21295-21312.
124. O'Malley Y, Fink BD, Ross NC, Prisinzano TE, Sivitz WI. Reactive oxygen and targeted antioxidant administration in endothelial cell mitochondria. J Biol Chem 2006; 281(52): 39766-39775. (Pubitemid 46041780)
125. Migrino RQ, Bright M, Hari P, et al. Endothelial dysfunction in human arterioles following exposure to primary amyloid light chain is improved by mitochondria-targeted antioxidant. J Am Coll Cardiol 2008; 51(10 Suppl A): A280.
126. Floyd RA. Antioxidants, oxidative stress, and degenerative neurological disorders. Proc Soc Exp Biol Med 1999; 222(3): 236-245. (Pubitemid 129708638)
127. Kotake Y. Pharmacologic properties of phenyl N-tert-butylnitrone. Antioxidant Redox Signal 1999; 1(4): 481-499.
128. Murphy MP, Echtay KS, Blaikie FH, et al. Superoxide activates uncoupling proteins by generating carbon-centered radicals and initiating lipid peroxidation: Studies using a mitochondria-targeted spin trap derived from alpha-phenyl-N-tert-butylnitrone. J Biol Chem 2003; 278(49): 48534-48545.
129. Skulachev VP, Anisimov VN, Antonenko YN, et al. An attempt to prevent senescence: A mitochondrial approach. Biochim Biophys Acta 2009; 1787(5): 437-461.
130. Antonenko YN, Avetisyan AV, Bakeeva LE, et al. Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 1. Cationic plastoquinone derivatives: Synthesis and in vitro studies. Biochemistry 2008; 73(12): 1273-1287.
131. Bakeeva LE, Barskov IV, Egorov MV, et al. Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 2. Treatment of some ROS- and age-related diseases (heart arrhythmia, heart infarctions, kidney ischemia, and stroke). Biochemistry 2008; 73(12): 1288-1299.
132. Anisimov VN, Bakeeva LE, Egormin PA, et al. Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 5. SkQ1 prolongs lifespan and prevents development of traits of senescence. Biochemistry 2008; 73(12): 1329-1342.
133. Zhao K, Zhao GM, Wu D, et al. Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury. J Biol Chem 2004; 279(33): 34682-34690. (Pubitemid 39318098)